MDS (MDZ) and Danaher Corp. (DHR) Announce Receipt of Second Request from U.S. FTC for MDS Analytical Tech Sale

November 3, 2009 9:31 AM EST

MDS Inc. (NYSE: MDZ) and Danaher Corporation (NYSE: DHR) today announced that they have each received a Second Request for information from the Federal Trade Commission (FTC) regarding the sale of MDS Analytical Technologies.

The Second Request relates to a global market segment that MDS and Danaher estimate generates less than $50 million in annual revenues for all sellers combined.

The information request was issued under notification requirements of the Hart Scott Rodino Antitrust Improvements Act of 1976, as amended (HSR Act). The effect of the Second Request is to extend the waiting period imposed by the HSR Act for a period of 30 calendar days from the date of the parties' substantial compliance with the request, unless the waiting period is earlier terminated.

MDS Inc. and Danaher Corporation continue to cooperate with the FTC and currently expect the transaction, which was announced on September 2, 2009 and received approval from MDS shareholders on October 20, 2009, to close before the end of the first calendar quarter of 2010, subject to the satisfaction of the conditions to closing.

Related Categories

Corporate News

Stocks Mentioned

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?